Although prevention and treatment strategies are available for influenza, they are not sufficient for vulnerable populations such as young children and newborns. In a new study published in Virology, a multidisciplinary team ...
Mar 18, 2024
0
0
Not all medical conditions have names that spell out their meaning, but "walking pneumonia" seems to be an exception.
Feb 26, 2024
0
0
A recent collaborative study has developed a microphysiological system to study the effects of COVID-19. The model consists of bronchial organoids and vascular beds and reveals the interactions between the bronchi and vasculature ...
Jan 31, 2024
0
1
Respiratory syncytial virus (RSV) is one of the main reasons leading to hospitalization among young children worldwide and each year, an estimated 101,000 children below the age of 5 years die due to RSV infections. Since ...
Jan 29, 2024
0
0
Clinical research led by Indiana University School of Medicine investigators and their collaborators in Uganda has revealed that hydroxyurea significantly reduces infections in children with sickle cell anemia. Their latest ...
Jan 29, 2024
0
0
A jump in the number of people with serious illness caused by group A Streptococcus—also referred to as Streptococcus pyogenes or Strep A—has made headlines recently. There has also been a higher than usual number of ...
Jan 24, 2024
0
1
Viral respiratory infections are a significant public health concern. A study published January 18 in the open access journal PLOS Biology by Marta Galanti at Columbia University, New York, United States and colleagues used ...
Jan 18, 2024
0
0
Rupak Datta, MD, Ph.D., MPH, is an assistant professor of medicine (infectious diseases) at Yale School of Medicine (YSM) and an assistant hospital epidemiologist in the Veterans Affairs Connecticut Healthcare System. His ...
Jan 17, 2024
0
14
Respiratory syncytial virus (RSV) is one of the leading pathogens that cause lower respiratory tract infections in infants and the elderly. Passive immunoprophylaxis with monoclonal antibody (mAb) has been approved to prevent ...
Dec 29, 2023
0
1
Nirsevimab is efficacious for preventing hospitalization for respiratory syncytial virus (RSV)-associated lower respiratory tract infection among infants, according to a study published in the Dec. 28 issue of the New England ...
Dec 29, 2023
0
0
